Integra LifeSciences Valuation

IART Stock  USD 29.38  0.40  1.38%   
At this time, the firm appears to be undervalued. Integra LifeSciences retains a regular Real Value of $34.46 per share. The prevalent price of the firm is $29.38. Our model calculates the value of Integra LifeSciences from evaluating the firm fundamentals such as Return On Asset of 0.0424, current valuation of 3.64 B, and Return On Equity of 0.0399 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage acquiring undervalued assets and selling overvalued assets since, at some point, asset prices and their ongoing real values will come together. Key fundamental drivers impacting Integra LifeSciences' valuation include:
Price Book
1.6236
Enterprise Value
3.6 B
Enterprise Value Ebitda
15.4351
Price Sales
1.6724
Forward PE
9.9404
Undervalued
Today
29.38
Please note that Integra LifeSciences' price fluctuation is very steady at this time. Calculation of the real value of Integra LifeSciences is based on 3 months time horizon. Increasing Integra LifeSciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Integra LifeSciences Holdings is useful when determining the fair value of the Integra stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Integra LifeSciences. Since Integra LifeSciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Integra Stock. However, Integra LifeSciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  29.38 Real  34.46 Target  46.89 Hype  28.92
The real value of Integra Stock, also known as its intrinsic value, is the underlying worth of Integra LifeSciences Company, which is reflected in its stock price. It is based on Integra LifeSciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Integra LifeSciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Integra LifeSciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
34.46
Real Value
37.04
Upside
Estimating the potential upside or downside of Integra LifeSciences Holdings helps investors to forecast how Integra stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Integra LifeSciences more accurately as focusing exclusively on Integra LifeSciences' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.530.550.58
Details
Hype
Prediction
LowEstimatedHigh
26.3428.9231.50
Details
13 Analysts
Consensus
LowTarget PriceHigh
42.6746.8952.05
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Integra LifeSciences' intrinsic value based on its ongoing forecasts of Integra LifeSciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Integra LifeSciences' closest peers. When choosing an evaluation method for Integra LifeSciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Integra LifeSciences Investments

(89.47 Million)

Integra Valuation Trend

Knowing Integra LifeSciences' actual value is paramount for traders to make sound investment determinations. Integra LifeSciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Integra LifeSciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Integra LifeSciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Integra Market Cap

Integra LifeSciences Holdings is rated second overall in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 12 Billion. Integra LifeSciences retains roughly 2.28 Billion in market capitalization claiming about 19% of equities under Health Care industry.
Capitalization  Valuation  Total debt  Revenue  Workforce

Integra LifeSciences Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Integra LifeSciences's current stock value. Our valuation model uses many indicators to compare Integra LifeSciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Integra LifeSciences competition to find correlations between indicators driving Integra LifeSciences's intrinsic value. More Info.
Integra LifeSciences Holdings is rated third overall in price to earning category among related companies. It is rated fourth overall in price to book category among related companies fabricating about  0.06  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Integra LifeSciences Holdings is roughly  16.59 . Price To Book Ratio is likely to gain to 3.53 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Integra LifeSciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Integra LifeSciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Integra LifeSciences' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Integra LifeSciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Integra LifeSciences and how it compares across the competition.

About Integra LifeSciences Valuation

The stock valuation mechanism determines the current worth of Integra LifeSciences Holdings on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Integra LifeSciences Holdings. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Integra LifeSciences based exclusively on its fundamental and basic technical indicators. By analyzing Integra LifeSciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Integra LifeSciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integra LifeSciences. We calculate exposure to Integra LifeSciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Integra LifeSciences's related companies.
Last ReportedProjected for Next Year
Gross Profit888.4 M458 M
Pretax Profit Margin 0.05  0.06 
Operating Profit Margin 0.11  0.12 
Net Profit Margin 0.04  0.05 
Gross Profit Margin 0.58  0.50 

8 Steps to conduct Integra LifeSciences' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Integra LifeSciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Integra LifeSciences' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Integra LifeSciences' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Integra LifeSciences' revenue streams: Identify Integra LifeSciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Integra LifeSciences' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Integra LifeSciences' growth potential: Evaluate Integra LifeSciences' management, business model, and growth potential.
  • Determine Integra LifeSciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Integra LifeSciences' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Integra LifeSciences Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Integra LifeSciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding80.3 M
Quarterly Earnings Growth Y O Y-0.601
Forward Price Earnings9.9404

Integra LifeSciences Current Valuation Indicators

Valuation refers to the process of determining the present value of Integra LifeSciences Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Integra we look at many different elements of the entity such as Integra's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Integra LifeSciences' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Integra LifeSciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Integra LifeSciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Integra LifeSciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Integra LifeSciences' worth.
When determining whether Integra LifeSciences is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Integra Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Integra Lifesciences Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Integra Lifesciences Holdings Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Integra Stock analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Integra LifeSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.60)
Earnings Share
0.84
Revenue Per Share
19.248
Quarterly Revenue Growth
(0)
Return On Assets
0.0424
The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.